Johan M. Spoor - 25 Nov 2024 Form 4/A - Amendment Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
CEO, Director
Signature
/s/ Johan (Thijs) Spoor by Chris Nenno, as Attorney-in-Fact
Issuer symbol
CATX
Transactions as of
25 Nov 2024
Net transactions value
$0
Form type
4/A - Amendment
Filing time
04 Dec 2024, 17:15:03 UTC
Date Of Original Report
26 Nov 2024
Previous filing
24 Jun 2024
Next filing
04 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CATX Common Stock 28,257 25 Nov 2024 Direct F1
holding CATX Common Stock 5,400 25 Nov 2024 By IRA of Reporting Person
holding CATX Common Stock 12,600 25 Nov 2024 By IRA of Spouse F2
holding CATX Common Stock 1,000 25 Nov 2024 By Child F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Beneficial ownership was reported to be 152,072 and should have been reported as 28,257.
F2 Indirect beneficial ownership was reported to be 66,600 and should have been reported as 12,600.
F3 Indirect beneficial ownership was reported to be 10,000 and should have been reported as 1,000.

Remarks:

This Form 4/A is being filed to correct certain previously reported information regarding the beneficial ownership of the Reporting Person as reflected in the original Form 4 filed on November 26, 2024 (the "Original Form 4"). Certain amounts reported in the Original Form 4 did not reflect the 1-for-10 reverse stock split effected by the Issuer in June 2024; such amounts have been updated accordingly herein.